RHA Fillers Ultra XC With Lidocaine Granted FDA Approval

Published February 8, 2010 by Dr. Mark Mandell-Brown

By coincidence last week, as we posted about wrinkle fillers with lidocaine, Allergan was announcing FDA clearance for the new RHA Fillers Ultra XC. The company is citing results from their clinical trial in which 93 percent of patients reported reduced pain with the new formulation. They are now marketing RHA Fillers XC as a comfortable alternative to regular RHA Fillers.

Facts to know about RHA Fillers XC

• Contains a small amount (0.3%) of local anesthetic
• Composed of colorless hyaluronic acid – a hydrator and cushioning agent
• Results last about 9 -12 months
• Those allergic to lidocaine or Gram-positive bacterial proteins should not use RHA Fillers XC
• Traditional pain control methods can still be used to further minimize discomfort
• Safety profile and frequency of side effects is very similar to non-lidocaine RHA Fillers